Blogs about: Exubera
Featured Blog
Further reporting on Exubera
Today’s Wall Street Journal has a front page article on Pfizer’s decision to drop Exubera. It covers some of the history of Exubera development and also points out some of it’s short… more →
Bernard's Diabetes Blog
Exubera hmm... not good
Webmaster wrote 1 year ago: This article was sent to me by my fellow blogger, Ben who suggested that this might be an interestin … more →
Questioning of Lung as Safe Site for Drug Disposition Heightens
Audrey Erbes wrote 1 year ago: The latest news of higher levels of lung cancer with Exubera supports those who have questioned … more →
Pfizer Lays Off 660
kurtglmft wrote 1 year ago: According to the Indianapolis Star, Pfizer Inc. is eliminating 660 jobs at it’s plant near Ter … more →
BIOTECH STOCKS: 2007 WINNERS AND LOSERS
danielteper wrote 1 year ago: New York, NY based Imclone (NASDAQ:IMCL) spiked 65% in 2007 on the promise of its only drug, Erbit … more →
Can we count out Pfizer?
— 1 comment
KHOI wrote 1 year ago: Pfizer just pulled their Exubera (inhaled insulin) from market. A horrible way to end a horrible ye … more →
Inhaled Insulin
Prolificus Madison wrote 1 year ago: The New York Times has an article about Alfred E. Mann, a billionaire who has a lot of money to spen … more →
Exubera shows the importance of having an exit strategy
silico wrote 1 year ago: Pfizer has announced that it will drop Exubera, its poorly selling inhaled insulin developed in part … more →
Prescription Drugs and The Unimpressive
Brian wrote 1 year ago: Have you seen any of the recent ads for the new prescription drugs that are available for erectile d … more →
Further reporting on Exubera
— 1 comment
Bernard Farrell wrote 1 year ago: Today’s Wall Street Journal has a front page article on Pfizer’s decision to drop Exuber … more →
Pharma News 10_19
— 2 comments
Steve Woodruff wrote 1 year ago: The Good Stuff: BMS gets approval for new oncology drug (for breast cancer) Ixempra. Merck gets new … more →
Pfizer drops Exubera insulin inhaler
— 2 comments
Bernard Farrell wrote 1 year ago: You probably have seen the news on this from other blogs. The first I read about it today was on Sco … more →
Nektar Crushed Under Pfizer's Boot (NKTR, PFE)
247wallst wrote 1 year ago: Nektar Therapeutics (NASDAQ:NKTR) is seeing shares hitting 52-week lows after its pharmaceutical par … more →
Oriel to receive third round funding for new inhaler technology
KHOI wrote 1 year ago: Oriel Therapeutics is a lab out of Research Triangle Park, NC. They just went through third round … more →
Inhaled Insulin - Information about Exubera
benbeetis wrote 1 year ago: With all of the advertising I see about Exubera I felt the need to provide a comprehensive list of a … more →
Hexubera promotion goes terribly wrong
— 3 comments
Steve Woodruff wrote 1 year ago: What seemed, at first, to be a terrific marketing idea ended in disaster this week, when, in the dea … more →
Have your say. Start a blog.
See our free features →
An 
Invention
